Le Lézard
Classified in: Health
Subject: ATY

Dentsply Sirona Investor Alert: Hagens Berman Alerts Dentsply Sirona, Inc. Investors to Investigation of Potential Securities Law Violations Connected to SEC Enforcement Inquiry and Management Shakeup


SAN FRANCISCO, Oct. 6, 2017 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors that it is investigating Dentsply Sirona, Inc. (NASDAQ: XRAY) for possible securities law violations.  If you purchased or otherwise acquired securities of Dentsply Sirona before October 3, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP.  For more information visit:

https://www.hbsslaw.com/cases/XRAY

or contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing

[email protected].

Hagens Berman Sobol Shapiro LLP

On August 9, 2017, Dentsply Sirona announced in its Form 10-Q filing that the SEC's Division of Enforcement "has asked the Company to provide documents and information concerning the Company's accounting and disclosures, including its accounting and disclosures relating to transactions with a significant distributor of the Company."  In reaction, Dentsply Sirona's share price fell $5.18, or 8.4%, to close at $56.23 on August 9, 2017.

On October 2, 2017, Dentsply Sirona announced that three top executives tendered their resignations: CEO Jeffrey Slovin, Executive Chairman Bret Wise, and President and Chief Operating Officer Christopher Clark.  This news drove the price of Dentsply Sirona shares down $3.48, or 5.8%, to close at $56.33 on October 2, 2017.

The next day, The Wall Street Journal reported the Company's board forced these executives out.

"We're focused on the matters triggering the SEC's inquiry, the extent of improper accounting if any, and the possible roles of the recently-departed executives," said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding Dentsply Sirona should consider their options to help in the investigation or take advantage of the SEC Whistleblower Program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email [email protected].

About Hagens Berman 
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 11 offices across the country.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.   More about the firm and its successes can be found at www.hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

SOURCE Hagens Berman Sobol Shapiro LLP


These press releases may also interest you

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...



News published on and distributed by: